CareCloud (CCLD) Stock: Buy, Sell, or Hold?

CCLD - CareCloud, Inc. Common Stock

SERVICES-PREPACKAGED SOFTWARE
$1.77
-0.05 (-2.75%) ▼
5d: +0.0%
30d: -17.67%
90d: -18.43%
HOLD
MODERATE Confidence
Analysis Updated: Oct 21, 2026 12:00 AM ET
Earnings: Nov 05, 2026 13d

Get Alerted When CCLD Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
📊 HOLD: CCLD shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
See Forward Earnings Fair Value & Price Prediction →

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$2.20
Based on -6.2% avg growth
INTRINSIC VALUE TODAY
$1.37
Trading above historical range

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 10.1x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: CCLD is currently trading at $1.77, which is considered oversold relative to its 30-day fair value range of $1.89 to $2.12. From a valuation perspective, the stock is trading at a discount (Forward PE: 5.8) compared to its historical average (10.1). Remarkably, the market is currently pricing in an annual earnings decline of 17.0% over the next few years. This aligns with recent fundamental challenges.

Technical Outlook: Technically, CCLD is in a uptrend. The price is currently testing key support at $1.73. A bounce from this level would confirm strength, while a break below could signal further downside.

Market Sentiment: CCLD scores 32/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $7.33 (+314.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position OVERSOLD
Historical Trading Range $1.89 - $2.12
Company Quality Score 56/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 57.1%

All Signals

  • BULLISH: Price oversold vs 30-day range
  • BEARISH: Weak technical setup (32/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 314.3% below Wall St target ($7.33)

Trading Range Analysis

30-Day Trading Range $1.89 - $2.12
Current vs Trading Range OVERSOLD

Support & Resistance Levels

Support Level $1.73
Resistance Level $2.02
Current Trend Uptrend
Technical data as of Oct 21, 2026

Fundamental Context

Forward P/E (Next Year Est.) 5.80
Wall Street Target $7.33 (+314.3%)
Revenue Growth (YoY) 16.4%
Earnings Growth (YoY) -88.3%
Profit Margin 6.2%
Valuation Discount vs History -17.0% cheaper
PE vs Historical 5.8 vs 10.1 CHEAP
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): -17.0% (market-implied from PE analysis)
1-Year Target $1.59 (-10%)
2-Year Target $1.43 (-19%)
3-Year Target $1.29 (-27%)
3-Yr Target (if PE normalizes) (PE: 6→10) $2.25 (+27%)
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 19.9, Growth: -16.4%) $4.42 (+150%)
Base: (SPY PE: 5.8, Growth: -16.4%) $1.29 (-27%)
Bear: (PE: 4.9, Growth: -16.4%) $1.10 (-38%)
📈 Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (30x PE), but valuation improves significantly next year (6x PE) as earnings recover.
Trailing PE: 30.33 | Current EPS (TTM): $0.06
Bull Case $4.00 (+126%)
Analyst growth 100.0%, PE expands to 33.4
Base Case $3.64 (+106%)
Market implied 100.0%, PE stable at 30.3
Bear Case $1.24 (-30%)
Severe decline -20.0%, PE contracts to 25.8
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡 Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 5.8 to 10.1
Stabilization Target: $3.08 (+74.0%)
PE Expansion Potential: +74.0%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: October 21, 2026 11:21 PM ET
Data refreshes hourly during market hours. Next update: 12:21 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for CCLD.

Create Free Account

Already have an account? Log In

Top Rated Health Information Services Stocks

Top-rated stocks in Health Information Services by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
VEEV
Veeva Systems Inc Class A
BUY
29 analysts
$297 30 SELL
BTSG
BrightSpring Health Serv…
STRONG BUY
18 analysts
$79 51 HOLD
WAY
Waystar Holding Corp. Co…
STRONG BUY
23 analysts
$34 33 SELL
GEHC
GE HealthCare Technologi…
STRONG BUY
21 analysts
$90 40 SELL
HNGE
Hinge Health, Inc.
STRONG BUY
17 analysts
$112 39 SELL

More Analysis for CCLD

CCLD Technical Chart CCLD Price Prediction CCLD Earnings Date CCLD Investment Advisor CCLD Fair Price Analyzer CCLD Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals